Evidence map›Paper›PMID 30463566›Full record

ArticleRespiratory research2018

Alterations in VASP phosphorylation and profilin1 and cofilin1 expression in hyperoxic lung injury and BPD.

Mehboob Ali, Kathryn Heyob, Trent E Tipple, Gloria S Pryhuber, Lynette K Rogers

Open access · goldAbstract read
In one paragraph

Article in Respiratory research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. CD146: a promising target in respiratory diseases.European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Cortactin in Lung Cell Function and Disease.International journal of molecular sciences · 2022
    Review
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Mehboob AliCenter for Perinatal Research, The Research Institute at Nationwide Children's Hospital, 575 Children's Cross Road, Columbus, OH, USA. mehboob.ali@nationwidechildrens.org.ORCID http://orcid.org/0000-0003-1657-7245
Kathryn HeyobCenter for Perinatal Research, The Research Institute at Nationwide Children's Hospital, 575 Children's Cross Road, Columbus, OH, USA.
Trent E TippleDepartment of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, USA.
Gloria S PryhuberDepartment of Pediatrics, University of Rochester Medical Center, Rochester, NY, USA.
Lynette K RogersCenter for Perinatal Research, The Research Institute at Nationwide Children's Hospital, 575 Children's Cross Road, Columbus, OH, USA.
Nationwide Children's Hospital · USUniversity of Alabama at Birmingham · USUniversity of Rochester Medical Center · US

Funding

Targeting Thioredoxin Reductase-1 to Prevent Bronchopulmonary DysplasiaR01HL119280 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI TIPPLE, TRENT · 2014 to 2018
$2.0M
DHA attenuates Inflammatory Responses Through Altering RAGE SignalingR01AT006880 · NCCIH · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI ROGERS, LYNETTE KAY · 2011 to 2015
$1.8M
National Institutes of Health R01AT006880National Institutes of Health R01HD0880833National Institutes of Health R01HL119280NCCIH NIH HHS R01 AT006880NHLBI NIH HHS R01 HL119280
6 · The paper itself

Abstract

backgroundHyperoxia is a frequently employed therapy for prematurely born infants, induces lung injury and contributes to development of bronchopulmonary dysplasia (BPD). BPD is characterized by decreased cellular proliferation, cellular migration, and failure of injury repair systems. Actin binding proteins (ABPs) such as VASP, cofilin1, and profilin1 regulate cell proliferation and migration via modulation of actin dynamics. Lung mesenchymal stem cells (L-MSCs) initiate repair processes by proliferating, migrating, and localizing to sites of injury. These processes have not been extensively explored in hyperoxia induced lung injury and repair.

methodsABPs and CD146

resultsDecreased F-actin content, ratio of VASP

conclusionAltered phosphorylation of VASP and expression of profilin 1 and cofilin 1 in human tissues indicate that the pathophysiology of BPD involves dysregulation of actin binding proteins. Lack of similar changes in a mouse model of hyperoxia exposure imply that disruption in actin binding protein expression may be linked to interventions or morbidities other than hyperoxia alone.

Indexed as

AnimalsAnimals, NewbornBronchopulmonary DysplasiaCell Adhesion MoleculesCofilin 1FemaleGene ExpressionHumansHyperoxiaInfant, NewbornLung InjuryMiceMice, Inbred C3HMicrofilament ProteinsPhosphoproteinsPhosphorylationCell Adhesion MoleculesCofilin 1Microfilament ProteinsPFN1 protein, humanPhosphoproteinsProfilinsVasodilator-Stimulated PhosphoproteinActin binding proteinsBPDCD146Cofilin1HyperoxiaL-MSCsProfilin1VASPVASPpS157VASPpS239

Identifiers

PMID30463566
PMCPMC6249974
OpenAlexW2900902151

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.